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Abstract O128 is one of the most common atypical entero-
pathogenic Escherichia coli isolated from diarrhea patients
worldwide. The primary structure of E. coli O128 repeat units
has previously been determined as C3)-L-D-GalNAc-(1C4)-
K-D-Gal-(1C3)-L-D-GalNAc-(1C6)-[K-L-Fuc-(1C2)]-L-D-Gal-
(1C pentasaccharide. Here we report the complete sequencing
of E. coli O128 antigen biosynthesis gene cluster and its £ank-
ing regions. Comparative sequence analysis revealed the ex-
pected O128 antigen process genes, GDP-fucose biosynthesis
genes and four potential glycosyltransferase genes responsible
for the assembly of E. coli O128 antigen repeats. WbsJ was
shown to encode an K-1,2-fucosyltransferase by enzymatic as-
says and nuclear magnetic resonance spectroscopy analysis.
3 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Enteropathogenic Escherichia coli (EPEC) is a leading cause
of infantile diarrhea in developing countries. In industrialized
countries, the frequency of these organisms has decreased, but
they continue to be an important cause of diarrhea [1]. EPEC
are divided into typical and atypical subgroups based on the
presence of the adherence factor (EAF) plasmid [2]. The most
studied EPEC strains belong to a series of O-antigenic sero-
types known as EPEC O serogroups. As one of the most
common atypical EPEC, E. coli O128 strains have been iso-
lated from diarrhea patients worldwide, for example, in Brazil
[3], England [4], Peru [5], Italy [6] and Singapore [7].
Bacterial lipopolysaccharides (LPS) typically consist of a
hydrophobic domain known as lipid A, a core oligosaccha-
ride, and a distal polysaccharide (O antigen) that contributes
major antigenic variability to the cell surface [8]. The O poly-
saccharide repeat units are synthesized from sugar nucleotides
by glycosyltransferases that are often soluble or peripheral
membrane proteins, and assembled on the membrane-bound
carrier, undecaprenyl phosphate (undP), at the inner face of
the cytoplasmic membrane [8]. The genes involved in the bio-
synthesis of O antigens in E. coli are generally clustered ad-
jacent to the gnd gene between the colanic acid and his oper-
ons [9].
The need for potent vaccines against infectious diseases is
becoming more urgent as antibiotic-resistant pathogens con-
tinue to emerge. Vaccines consisting of carbohydrates coupled
to a protein carrier have been proven e¡ective for the preven-
tion of invasive bacterial disease [10]. However, these glyco-
conjugates prepared by using puri¢ed polysaccharides or de-
graded oligosaccharides are sometimes contaminated with
other bacterial components. They may also have ill-de¢ned
structures due to multiple coupling sites [11]. The molecular
size of carbohydrate antigens is another major concern in
designing glycoconjugate vaccines [12,13]. Large polysaccha-
rides may decrease the solubility of glycoconjugates, and size-
unconstrained antigens may yield heterogeneous conjugates
with the potential for immunogenic inconsistency [14]. There-
fore, the structurally de¢ned glycoconjugates generated from
synthetic carbohydrate antigens with desired molecular sizes
are especially attractive in our battle against infectious dis-
eases. The exploration of these well-structured glycoconjugate
vaccines has been hindered largely by the technical di⁄culties
in chemical preparation of oligosaccharides.
The primary structure of LPS O-speci¢c polysaccharide
(Fig. 1) from E. coli O128 has been established [15]. The
immunodominant part of E. coli O128 polysaccharide was
determined as L-D-GalNAc-(1C6)-[K-L-Fuc-(1C2)]-L-D-Gal
trisaccharide by ELISA-inhibition study [16]. It can be envi-
sioned that the e⁄cient synthesis of the oligosaccharide would
pave the way for the development of a well-structured glyco-
conjugate vaccine against infantile diarrhea E. coli O128.
Compared to chemical synthesis, the enzymatic approach uti-
lizing glycosyltransferases has been proven more e⁄cient in
the production of complex carbohydrates. Considering the
extremely narrow substrate speci¢city of most known glyco-
syltransferases, molecular characterization of the biosynthetic
pathway of O128 antigen repeat units is undoubtedly a crucial
step towards large-scale synthesis of the immunodominant ol-
igosaccharide. In this study, we sequenced the E. coli O128
O-antigen gene cluster and its £anking regions to elucidate the
genetic basis of O128 antigen biosynthesis. Sequence analysis
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revealed ¢ve genes involved in GDP-fucose (GDP-Fuc) bio-
synthesis and all three O128 antigen processing genes. More
important, we assigned four potential glycosyltransferases re-
sponsible for the assembly of E. coli O128 antigen repeats.
The K-1,2-fucosyltransferase function of gene WbsJ was un-
ambiguously determined by enzymatic assays and nuclear
magnetic resonance (NMR) spectroscopy analysis.
2. Materials and methods
2.1. Bacterial strains and plasmids
E. coli O128:B12:H (ATCC 12810) was obtained from American
Type Culture Collection (Rockville, MD, USA). E. coli TOP10 strain
and linearized pCR4Blunt-TOPO vector were from Invitrogen (Carls-
bad, CA, USA). The pGEX-4T-1 plasmid was from Amersham Bio-
sciences (Piscataway, NJ, USA). GSTWBind kit was from Novagen
(Madison, WI, USA).
2.2. Polymerase chain reaction (PCR) and random shotgun cloning
The chromosomal DNA of E. coli O128 was prepared by ELU-
QUIK DNA puri¢cation kit from Schleicher and Schuell Bioscience
(Keene, NH, USA). Long-range PCR was carried out by using Mas-
terAmp1 extra-long PCR kit from Epicentre (Madison, WI, USA). A
pair of primers: F (5P-GCTTTCTGCCGATATTTGGC) and R (5P-
CCGACGGACTGATGCCGGTGATT) were designed based on the
highly conserved sequences of E. coli galF and HisI genes, respec-
tively. A total of 15 PCR products were pooled to minimize the e¡ect
of PCR errors. After gel puri¢cation, the PCR products were sheared
by nebulizers (Invitrogen) and cloned into pCR4Blunt-TOPO vector
to generate a bank (280 colonies) according to the instruction manual
of the TOPO shotgun cloning kit (Invitrogen).
2.3. Sequencing and analysis
The plasmids for sequencing were prepared with QIAprep 96 Turbo
Miniprep kit by using the BioRobot 9600 of Qiagen (Valencia, CA,
USA). Sequencing was performed by an Applied Biosystems 3700
DNA analyzer (Foster City, CA, USA) at Wayne State University
DNA sequencing facility. The whole DNA sequence was assembled
by the Phred/Phrap package from the Genome Center of the Univer-
sity of Washington. The open reading frames (ORFs) were recognized
and selected by using the ORF Finder from the National Center for
Biotechnology Information (NCBI). The BLAST database was used
to search for sequence homologies and the amino acid sequence align-
ments were performed using CLUSTAL W [17]. Potential transmem-
brane segments were identi¢ed by TMpred [18].
2.4. Cloning and expression of wbsJ gene
The WbsJ gene was cloned into the BamHI and XhoI sites of
pGEX-4T-1 plasmid with an N-terminal glutathione S-transferase
(GST) tag. A pair of primers: P1 5P-CGCGGATCCATGGAAGT-
TAAAATTATTGGGG-GGCT/P2 5P-CGGAATTCTCGAGTCAT-
AATTTTACCCACGATTCG, with BamHI and XhoI restriction sites
(underlined) incorporated into P1 and P2, respectively, were used for
PCR ampli¢cation of wbsJ gene from chromosomal DNA. The plas-
mid pGEX/WbsJ was transformed into E. coli BL21 (DE3) for ex-
pression. The 1-l Luria^Bertani broth culture was induced with 1 mM
isopropyl-1-thio-L-D-galactospyranoside (30‡C, 10 h). The pelleted
cells were stored at 380‡C until needed.
The cell pellet was resuspended in GST Bind/Wash bu¡er (4.3 mM
Na2HPO4, 1.47 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.3)
and disrupted by sonication (Branson Soni¢er 450, VWR Scienti¢c)
on ice. The lysate was cleared by centrifugation and loaded onto a
GST-Bind column (Novagen). After washing by ¢ve volumes of the
same bu¡er, the protein was eluted by GST elution bu¡er (50 mM
Tris^HCl, 10 mM reduced glutathione, pH 8.0).
2.5. Fucosyltransferase activity assay
The enzyme assays were performed at 37‡C for 2 h in a ¢nal volume
of 50 Wl containing 20 mM Tris^HCl (pH 7.0), 10 mMMnCl2, 0.3 mM
GDP-L-[U-14C]Fuc (7000 cpm), 10 mM acceptor galactose (Gal) and
various amounts of puri¢ed enzyme. Acceptor was omitted for blank.
The reaction was terminated by adding 100 Wl of ice-cold 0.1 M
EDTA. Dowex 1U8-200 chloride anion exchange resin was then
added. After centrifugation, the radioactivity of the supernatant was
counted in a liquid scintillation counter (Beckmann LS-3801 counter).
One unit of activity is de¢ned as the amount of enzyme that catalyzes
the transfer of 1 Wmol of Fuc from GDP-Fuc to acceptor per minute
at 37‡C.
2.6. NMR spectroscopy
1H and 13C NMR spectra were recorded by 500 MHz Varian
VXR500 NMR spectrometer. Product structure was identi¢ed by
one-dimensional (selective COSY, relay COSY, and NOE) and two-
dimensional (COSY, HMQC, NOESY, and HMBC) 1H/13C NMR.
The oligosaccharide product was repeatedly dissolved in D2O and
lyophilized before NMR spectra were recorded at 303 K in a 5 mm
tube.
2.7. Nucleotide sequence accession number
The DNA sequence of E. coli O128 antigen biosynthesis gene clus-
ter has been deposited in GenBank under the accession number
AY217096.
3. Results and discussion
The total of 19 013 bp E. coli O128 antigen biosynthesis
gene cluster, which covers a continuous region from the end
of galF gene to the middle of hisI, was ampli¢ed by long-
range PCR from the chromosomal DNA of E. coli O128
strain and completely sequenced. There are 16 predicted
ORFs within the gene cluster (Fig. 2), all in the same tran-
scriptional direction from galF to hisI gene. The E. coli O128
antigen repeat units consist of one L-Fuc, two Gal and two
N-acetylgalactosamine (GalNAc) residues. It is anticipated
that the cluster would contain genes responsible for GDP-L-
Fuc synthesis, genes coding glycosyltransferases to assemble
the O unit and genes for O-antigen process. The amino acid
Table 1
Summary of E. coli O128 antigen biosynthesis genes
ORF Name No. of
AA
Putative function
1 wbsH 373 Galactosyltransferase
2 gmd 374 GDP-mannose 4,6-dehydratase
3 fcl 321 GDP-Fuc synthetase
4 gmm 167 GDP-mannose mannosyl hydrolase
5 manC 482 GDP-mannose pyrophosphorylase
6 manB 459 Phosphomannomutase
7 wbsI 185 O-acetyltransferase
8 wzx 480 O-antigen £ippase
9 wbsJ 283 Fucosyltransferase
10 wbsK 288 Glycosyltransferase
11 wbsL 299 Glycosyltransferase
12 wzy 347 O-antigen polymerase
13 galE 339 UDP-glucose C4 epimerase
14 gnd 468 Gluconate 6-P dehydrogenase
15 ugd 388 UDP-glucose dehydrogenase
16 wzz 337 O-antigen chain length determinant
Fig. 1. Structure of E. coli O128 antigen.
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sequences were used to BLAST search previously character-
ized genes for possible functions.
It has been well established that GDP-L-Fuc is synthesized
from GDP-D-mannose via a three-step pathway catalyzed by
two enzymes, GDP-mannose 4,6-dehydratase (gmd) and
GDP-Fuc synthetase (fcl), common to both prokaryotic and
eukaryotic cells [19]. Three more enzymes, phosphomannose
isomerase (manA), phosphomannomutase (manB) and GDP-
mannose pyrophosphorylase (manC), are needed to generate
GDP-mannose from fructose 6-phosphate. Comparative se-
quence analysis revealed ¢ve genes involved in GDP-Fuc bio-
synthesis (Table 1), including a GDP-mannose mannosyl hy-
drolase (gmm), which catalyzes the hydrolysis of GDP-K-D-
mannose to yield GDP and L-D-mannose. This enzyme has
been suggested to participate in the regulation of cell wall
biosynthesis by in£uencing the concentration of GDP-man-
nose in the cell [20].
The E. coli O polysaccharides are normally synthesized in a
Wzy-dependent pathway, which consists of the assembly of
O-repeat units on the inner face of cytoplasmic membrane,
the exportation by O-antigen £ippase Wzx and the polymer-
ization by polymerase Wzy on the periplasmic face of cyto-
plasmic membrane [8]. The deduced amino acid sequence of
orf8 predicts a 55.3 kDa protein with 12 transmembrane seg-
ments. It shows low-level homology with some membrane
proteins such as Ta0703 from Thermoplasma acidophilum
and Wzx from Streptococcus pneumoniae. All these proteins
have similar functions, the translocation lipid-linked polysac-
charide repeat units across the cytoplasmic membrane. There-
fore, orf8 was named wzx. The orf12 encodes a protein with
10 transmembrane segments and two periplasmic regions of
40^50 amino acids. BLAST search indicates that it has low
homology with a group of polysaccharide polymerases, in-
cluding Wzy from E. coli O104 and Shigella boydii O6. So
orf12 was designated as wzy, O-antigen polymerase gene. The
orf16 was named wzz because it has 98% identity with chain
length determinant proteins from E. coli O157 and K12
strains.
Five sugar residues are present in E. coli O128 antigen
repeat unit. The ¢rst step in O polysaccharide biosynthesis
involves the formation of an und-PP-linked sugar by trans-
ferring a sugar 1-phosphate residue to undP [8]. It has been
shown that the wecA gene, responsible for adding the ¢rst
sugar to lipid carrier undP and initiating the O unit biosyn-
thesis, resides outside the E. coli O-antigen gene clusters [21].
Therefore, we expected to ¢nd only four glycosyltransferases
within O128 antigen biosynthesis gene cluster. The WecA pro-
tein homolog was proposed to transfer the ¢rst sugar 1-phos-
phate to undP on the cytoplasmic face of the cell membrane.
BLAST search revealed that the orf1, named wbsH, is ho-
mologous to a family of bacterial galactosyltransferases. The
closest homologs are WbgM (58% identity) from E. coli O55
and WbnE (36% identity) from E. coli O113 strain. The
WbgM has been previously suggested to be a galactosyltrans-
ferase that is responsible for the GalK1,3GalNAc linkage in
E. coli O55 repeat units [22]. Tentatively, we assigned WbsH
as an K (1C3) galactosyltransferase that makes the
GalK(1C3)GalNAc linkage.
The orf7 (wbsI) predicts a 20.5 kDa protein with high level
of homology to a large family of microbial acetyl transferases.
O polysaccharide acetylation has been found in a wide range
of pathogenic bacteria including E. coli [23,24]. It is suggested
that the O-acetyl groups play an essential role in the immu-
nogenicity and pathogenesis of these species [25^27]. Thus,
WbsI is likely an O-acetyltransferase that is responsible for
the acetylation of E. coli O128 O polysaccharide, though the
precise sugar residues modi¢ed are yet to be determined.
The WbsJ protein encoded by orf9 has a conserved domain
Fig. 2. E. coli O128 antigen biosynthesis gene cluster.
Fig. 3. Conserved motifs found in K (1C2) fucosyltransferases. The white letters with black background represent identical amino acids, while
the black letters with gray background represent similar amino acids conserved in all aligned sequences.
Table 2
500 MHz NMR 1H/13C chemical shift values of GalOMe and
FucK1,2GalOMe
Residue Group H/C N (ppm)
GalOMe FucK1,2GalOMe
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from glycosyltransferase family 11. This family mostly con-
sists of K (1C2) fucosyltransferases from di¡erent organisms
(http://afmb.cnrs-mrs.fr/CAZY). The WbsJ shows a low level
of similarity in amino acid sequence to its prokaryotic and
eukaryotic counterparts, with 35% identity to E. coli WbgN,
30% identity to Helicobacter pylori FucT2, 27% identity to
Yersinia enterocolitica WbcH and 22% identity to human
FUT2. However, multiple sequence alignment revealed that
WbsJ shares three highly conserved motifs with most of those
K (1C2) fucosyltransferases (Fig. 3). The motif II, which is
also shared by the K (1C6) fucosyltransferases from both
prokaryotic and eukaryotic origins, has been suggested to be
a part of the GDP-Fuc binding domain [28]. Therefore, we
propose that wbsJ encodes a fucosyltransferase that transfers
a Fuc residue to Gal in K (1C2) linkage.
The N-terminus of WbsK encoded by orf10 has a conserved
domain from glycosyltransferase family 2. The glycosyltrans-
ferases of this family transfer sugar residue with the inversion
of con¢guration. The amino acid sequence of WbsK shares
37%, 34%, 31% and 29% identities with Lactobacillus del-
brueckii EpsH, Streptococcus agalactiae CpsVIJ, Haemophilus
in£uenzae Rd LgtD [29] and S. pneumoniae Cps14J, respec-
tively. All these enzymes have been identi¢ed as L (1C4) or
L (1C3) GalNAc (or Gal) transferases, which participate in
the biosynthesis of microbial O-speci¢c or capsular polysac-
charides. Thus, we assigned WbsK as the N-acetylgalactosa-
minyltransferase that transfers a GalNAc residue to Gal in L
(1C4) linkage. WbsL shows low similarity to several group 1
putative bacterial polysaccharide transferases, and it is likely
to be the remaining L (1C6) N-acetylgalactosaminyltransfer-
ase.
To investigate the function of the wbsJ gene, we cloned this
gene into pGEX-4T-1 plasmid. The WbsJ was expressed in
E. coli BL21 (DE3) strain as a GST fusion protein and puri-
¢ed by one-step GST a⁄nity column. The fusion protein has
an apparent molecular weight of 59 kDa estimated by SDS^
PAGE (Fig. 4), similar to the theoretical value (59 806.2 Da)
calculated from its predicted amino acid sequence. Prelimi-
nary kinetic analysis shows that the fusion enzyme has Km
values of 138 WM and 120 mM to the donor GDP-Fuc and
acceptor methyl L-Gal, respectively. By using puri¢ed enzyme,
mg-scale synthesis was performed with GDP-Fuc and methyl
L-Gal as donor and acceptor substrates. Total 4.8 mg of di-
saccharide product was puri¢ed by Bio-Gel P2 gel ¢ltration to
allow 1H and 13C NMR spectroscopy analysis.
Signals were found for a newly introduced Fuc residue in
the NMR spectrum (Fig. 5) of the disaccharide product. A
coupling constant of 4 Hz for the H-1P resonance of Fuc
showed that this residue was linked in K-anomeric con¢gura-
tion (Table 2). The signi¢cant down¢eld increments in the
chemical shift of the C-2 resonance of Gal (vN=7.48 ppm),
but not in other resonances, indicated that the Fuc residue
had been introduced to C-2 of Gal residue. The linkage was
further con¢rmed by the two crosspeaks in the HMBC spec-
trum (data not shown). One crosspeak was between the C-1P
of Fuc and the H-2 of the Gal residue, the other was between
the H-1P of Fuc and the C-2 of the Gal residue. Therefore, the
structure of the disaccharide product was con¢rmed to be
FucK1,2GalOMe.
In conclusion, the complete E. coli O128 antigen biosynthe-
sis gene cluster was sequenced. All the genes required for the
biosynthesis of O antigen were identi¢ed by comparative se-
quence analysis. The K-1,2-fucosyltransferase function of wbsJ
gene was unambiguously determined by enzymatic assay and
NMR spectroscopy analysis. We believe that the elucidation
of O-antigen biosynthesis cluster sequence will help in the
design of an O128 PCR serotyping test and the development
of an O128 antigen-based, structurally de¢ned glycoconjugate
vaccine.
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